Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2)

Drugs in R&D(2024)10.1007/s40268-024-00483-5Source: DataRank Database

Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2) is a research paper published in Drugs in R&D (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.75)OA: goldTopics (54)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Kimberly E. Stelzig ORCID,Madeline R. Pellegrino,Marc Bindzus,Eunhee S. Yi ORCID,Andrew H. Limper ORCID

Live enrichment

PubMed:39105996 PMC:PMC11455733 OpenAlex:https://openalex.org/W4401368308

National Institutes of Health

Grant: R21AI181542-01

National Institutes of Health

Grant: R01 HL62150-30A1

NIAID NIH HHS

Grant: R21 AI181542

NHLBI NIH HHS

Grant: R01 HL062150

National Institutes of Health

Grant: 4R01HL062150-24

Pneumocystis carinii: Macrophage & Epithelial Activation

National Institutes of Health

Grant: 5R21AI181542-02

The Role of the EphA2 Receptor Kinase Pathway in Pneumocystis Pneumonia (PCP)

FWCI

0.75

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by-nc

journalhttps://link.springer.com/content/pdf/10.1007/s40268-024-00483-5.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s40268-024-00483-5.pdf

publisherhttps://link.springer.com/article/10.1007/s40268-024-00483-5/fulltext.html

journalhttps://doi.org/10.1007/s40268-024-00483-5

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39105996

Fields of Study

Axon Guidance and Neuronal SignalingMacrophage Migration Inhibitory FactorPharmacological Receptor Mechanisms and Effects03 medical and health sciences0302 clinical medicineAnimalsMiceReceptor, EphA2FemaleMaleCytokinesMice, Inbred C57BLLungBronchoalveolar Lavage FluidDrug Evaluation, PreclinicalDose-Response Relationship, Drug

MeSH Terms

AnimalsBronchoalveolar Lavage FluidDose-Response Relationship, DrugDrug Evaluation, PreclinicalFemaleLungMaleMice, Inbred C57BLCytokinesReceptor, EphA2Mice

Keywords

Proinflammatory cytokinePharmacologyBronchoalveolar lavageIn vivoPharmacokineticsImmunologyMedicineChemistryAndrologyLungInternal medicineInflammationBiologyBiotechnologyMaleDose-Response Relationship, DrugReceptor, EphA2Drug Evaluation, PreclinicalRM1-950Mice, Inbred C57BLMiceAnimalsCytokinesFemaleTherapeutics. PharmacologyOriginal Research ArticleBronchoalveolar Lavage Fluid